2Aosasa S,Ono S,Mochizuki H,et al.Mechanisn of the inhibitory effect of protease inhibitor on trmor necrosis factor alpha production of monocytes[J].Shock,2001,15:101-105.
3Okuhana Y,Shiraishi M,Higa T,et al.Protective effects of ulinastatin against ischemia reperfusion injury[J].J Surg Res,1999,82:34-42.
4Yamasaki F,Ishibashi M.Nakauki in mice and its effect on the lysosomal fragility[J].Nephron,1996,74:158-167.
5Aosasa S,Ono S,Seki S,et al.Inhibitory effect of protease inhibitor on endothelial cell activation[J].J Surg Res,1998,80:182-187.
二级参考文献3
1Kobayashi H,Shinohara H,Gotoh J,et al.Anti-metastasis therapy by urinary tyrpsin inhibitor in combination with an anti-cancer agent[].British Journal of Cancer.1995
2Hiyama A,Takeda J,Kotake Y,et al.A human urinary protease inhibitor (ulinastatin) inhibits neurrophil extracellular release of elastase during cardiopulmonary bypasss[].Journal of Cardiothoracic and Vascular Anesthesia.1997
3Kobayashi H,Shinohara H,Fujie M,et al.Inbibition of metastasis of lewis lung carcinoma by urinary trapsin inhibitor in experimental and spontaneous metastasis models[].International Journal of Cancer.1995
